• Home
  • Michael A Cahill
Michael A Cahill

Michael A Cahill
Honorary: Australian National University. Adjunct: Charles Sturt University. Advisor: Cognition Therapeutics.

BSc (Hons 1), PhD
Currently between positions. Prepared to work anywhere on a research project featuring PGRMC1.

About

116
Publications
8,168
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
3,169
Citations
Citations since 2017
26 Research Items
1025 Citations
2017201820192020202120222023050100150200
2017201820192020202120222023050100150200
2017201820192020202120222023050100150200
2017201820192020202120222023050100150200
Introduction
I followed a career path through signal transduction and gene regulation during my PhD and Postdoctoral time, into developing proteomics technologies, and applying those new technologies to biological conditions - especially cancer - at ProteoSys, a Biotechnology company that I co-founded. My recent research features a key protein that we discovered to be involved with cancer, called Progesterone Receptor Membrane Component 1 (PGRMC1). I left my full time university position in early 2021.
Additional affiliations
July 2008 - January 2021
Charles Sturt University
Position
  • Lecturer in Biochemistry and Cell Biology
Description
  • 30% Research, 60% teaching, 10% administration. In January 2021 I voluntarily left this position rather than to work at a university without being able to pursue research. I am currently available for recruitment to a research position anywhere internationally.
February 2004 - June 2008
Private authorship project
Position
  • Book Author (Paradise Rediscovered)
Description
  • Cahill MA (2012) Paradise rediscovered (Brisbane Glass House Books) 2 paperback (PB) volumes; 1 eBook ISBN 9781921869488 (Vol 1, PB, 556pp), ISBN 9781921869844 (Vol 2, PB, 543pp); ISBN 9781921869495 (Combined Vols 1&2 ePub) http://ipoz.biz/Titles/PR.htm
May 2000 - September 2007
Proteosys AG
Proteosys AG
Position
  • Chief Research Officer and Scientific Co-Founder
Education
April 1990 - August 1994
School of Pathology, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. External student in Germany
Field of study
  • Molecular Cell Biology
January 1983 - December 1987
School of Biological Sciences, Faculty of Science, University of New South Wales, Sydney, NSW, Australia
Field of study
  • Zoology & Biochemistry

Publications

Publications (116)
Article
Full-text available
Citation: Thejer, B.M.; Infantino, V.; Santarsiero, A.; Pappalardo, I.; Abatematteo, F.S.; Teakel, S.; Van Oosterum, A.; Mach, R.H.; Denora, N.; Lee, B.C.; et al. Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97. Int. Abstract: Sigma-2 receptor (S2R) is a S2R ligand-binding site historically associated with reportedly 2...
Article
Maintaining student engagement in online and recorded lectures is a challenging aspect of higher education. In light of this, active learning through in-lecture question activities was investigated using a pre-teaching focus group (n = 12) and student evaluations (n = 43) after an in-class trial. Data analysis was underpinned by flow theory, which...
Article
The title usage of Unde venisti ‘from where have you come’ is from a now dead language (Latin) that foundationally influenced modern English (not the major influence, but an essential formative one). This is an apt analogy for how both the ancient eukaryotic and eumetazoan functions of PGRMC proteins (PGRMC1 and PGRMC2 in mammals) probably influenc...
Article
The title usage of Latin Quo vadis ‘where are you going’ extends the question Unde venisti from where ‘did you come?’ posed in the accompanying paper and extends consideration of how ancient eukaryotic and eumetazoan functions of progesterone receptor membrane component (PGRMC) proteins (PGRMC1 and PGRMC2 in mammals) could influence modern human he...
Article
We recently reported that the membrane associated progesterone receptor (MAPR) protein family (mammalian members: PGRMC1, PGRMC2, NEUFC and NENF) originated from a new class of prokaryotic cytochrome b5 (cytb5) domain proteins, called cytb5M (MAPR‐like). Relative to classical cytb5 proteins, MAPR and ctyb5M proteins shared unique sequence elements...
Preprint
Full-text available
We recently reported that the membrane associated progesterone receptor (MAPR) protein family (mammalian members: PGRMC1, PGRMC2, NEUFC and NENF) originated from a new class of prokaryotic cytochrome b5 (cytb5) domain proteins, called cytb5M (MAPR-like). Relative to classical cytb5 proteins, MAPR and ctyb5M proteins shared unique sequence elements...
Preprint
Full-text available
The multiple functions of PGRMC1, the archetypal heme-binding eukaryotic MAPR family member, include steroidogenic regulation, membrane trafficking, and steroid responsiveness. The interrelationships between these functions are currently poorly understood. Previous work has shown that different MAPR subclasses were present early in eukaryotic evolu...
Article
Full-text available
In previous studies, we reported that progesterone receptor membrane component 1 (PGRMC1) is implicated in progestin signaling and possibly associated with increased breast cancer risk upon combined hormone replacement therapy. To gain mechanistic insight, we searched for potential PGRMC1 interaction partners upon progestin treatment by co-immunopr...
Article
Full-text available
This is a preface by the guest editors of the special issue of Cancers featuring the biology of progesterone (P4) receptor membrane component (PGRMC) proteins as it relates to metabolism and cancer [...]
Article
Full-text available
The σ-2 receptor (S2R) complex has been implicated in CNS disorders ranging from anxiety and depression to neurodegenerative disorders such as Alzheimer's disease (AD). The proteins comprising the S2R complex impact processes including autophagy, cholesterol synthesis, progesterone signaling, lipid membrane-bound protein trafficking, and receptor s...
Article
Full-text available
Background: Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Results: Here, we show that...
Article
Full-text available
Background: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Results: We demonstrate that manipulating PGRMC1 phosphory...
Article
The membrane-associated progesterone receptor (MAPR) family consists of heme-binding proteins containing a cytochrome b5 (cytb5) domain characterized by the presence of a MAPR-specific interhelical insert region (MIHIR) between helices 3 and 4 of the canonical cytb5-domain fold. Animals possess three MAPR genes (PGRMC-like, Neuferricin and Neudesin...
Preprint
Full-text available
Background: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Results: We demonstrate that manipulating PGRMC1 phosphorylat...
Preprint
Full-text available
Background: Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Results: Here, we show that mut...
Preprint
Full-text available
Background: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Results: We demonstrate that manipulating PGRMC1 phosphorylat...
Preprint
Full-text available
Background: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Results: We demonstrate that manipulating PGRMC1 phosphorylat...
Article
PGRMC1 is a protein from the MAPR family with a range of cellular functions. PGRMC1 has been described to play a role in fertility, neuroprotection, steroidogenesis, membrane trafficking and in cancer cell biology. PGRMC1 represents a likely key regulator of cell metabolism and proliferation, as well as a potential target for anti-cancer therapies....
Preprint
Full-text available
Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Here, we show that mutagenic manipulation o...
Preprint
Full-text available
Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily preceded deuterostome gastrulation and tissue differentiation mechanisms. Here, we demonstrate that manipulating PGRMC1 phosphorylation status in M...
Preprint
Full-text available
Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Here, we show that mutagenic manipulation o...
Preprint
Full-text available
Background The membrane-associated progesterone receptor (MAPR) family consists of heme-binding proteins containing a cytochrome b 5 (cytb 5 ) domain characterized by the presence of a MAPR-specific interhelical insert region (MIHIR) between helices 3 and 4 of the canonical cytb5-domain fold. Animals possess three MAPR families (PGRMC-like, Neuferr...
Article
Background: The cytomorphological features in the distinction between phyllodes tumour (PT) and fibroadenoma (FA) on fine needle aspiration biopsy (FNAB) remains challenging because of the biphasic nature of these lesions and the rarity of PT. Methods: FNAB smears of histologically confirmed PT (N = 26) and FA (N = 78) cases were retrieved from...
Article
A complex PGRMC1-centred regulatory system controls multiple cell functions. Although PGRMC1 is phosphorylated at several positions, we do not understand the mechanisms regulating its function. PGRMC1 is the archetypal member of the membrane associated progesterone receptor (MAPR) family. Phylogentic comparison of MAPR proteins suggests that the an...
Article
Progesterone Receptor Membrane Component 1 (PGRMC1) is located in many different subcellular locations with many different attested and probably location-specific functions. PGRMC1 was recently identified in the mitochondrial outer membrane where it interacts with ferrochelatase, the last enzyme in the heme synthetic pathway. It has been proposed t...
Article
Full-text available
// Michael A. Cahill 1 , Jalal A. Jazayeri 1 , Zaklina Kovacevic 2 and Des R. Richardson 2 1 School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia 2 Molecular Pharmacology and Pathology Program, Department of Pathology, Bosch Institute, University of Sydney, Sydney, NSW, Australia Correspondence to: Michael A. Cahill,...
Conference Paper
Automated and unbiased methods of non-invasive cell monitoring able to deal with complex biological heterogeneity are fundamentally important for biology and medicine. Label-free cell imaging provides information about endogenous fluorescent metabolites, enzymes and cofactors in cells. However extracting high content information from imaging of nat...
Article
Full-text available
Automated and unbiased methods of non-invasive cell monitoring able to deal with complex biological heterogeneity are fundamentally important for biology and medicine. Label-free cell imaging provides information about endogenous autofluorescent metabolites, enzymes and cofactors in cells. However extracting high content information from autofluore...
Conference Paper
Hyperspectral imaging based on endogenous contrast provides a new non-invasive method to characterise cells and tissues. Cellular content and maps of native fluorophores help monitor biological processes, with proper account of intrinsic cellular heterogeneity.
Article
Full-text available
Amyloid beta (Abeta) 1-42 oligomers accumulate in brains of patients with Mild Cognitive Impairment (MCI) and disrupt synaptic plasticity processes that underlie memory formation. Synaptic binding of Abeta oligomers to several putative receptor proteins is reported to inhibit long-term potentiation, affect membrane trafficking and induce reversible...
Article
Measurement of endogenous free and bound NAD(P)H relative concentrations in living cells is a useful method for monitoring aspects of cellular metabolism, because the NADH∕NADþ reduction-oxidation pair is crucial for electron transfer through the mitochondrial electron transport chain. Variations of free and bound NAD(P)H ratio are also implicated...
Article
The WHI trial suggests an increase of breast cancer in postmenopausal women probably according to the progestogenic compound, i.e. medroxyprogesterone acetate (MPA). However, the mechanism for a possible carcinogenic effect of MPA remains unclear so far. Progesterone receptor membrane component-1 (PGRMC1) may be important in tumorigenesis and thus...
Article
Clinical trials have demonstrated an increased risk of breast cancer during estrogen/norethisterone (NET) therapy. With this in mind, the effects of estrogen/NET combination on the proliferation of breast cancer cells overexpressing the progesterone receptor membrane component 1 (PGRMC1) were examined. The same combination was used for the first ti...
Article
Objectives: Dienogest (DNG) is already used in hormone therapy, since recently being also the progestogenic component of the first estradiol based contraceptive pill. Data on breast cancer risk are currently not available. Progesterone receptor membrane component 1 (PGRMC1) is highly expressed in tissues of breast cancer patients and has already b...
Book
Paradise Rediscovered. Were Europe's first farmers ruled by an elite aristocracy who passed themselves off as "gods", commanding secret knowledge that included ambrosia that extended their life spans? My first book published by Glass House Books, Brisbane is published as two paperback (PB) volumes or a single volume eBook. ISBN 9781921869488 (Vol 1...
Article
Objectives: Recently the first monophasic contraceptive pill containing estradiol has been developed which is thought to be a milestone in contraception. Nomegestrol acetate (NOM) is the progestogenic component. Progesterone receptor membrane component 1 (PGRMC1) is highly expressed in the tissue of breast cancer patients, and can predict a proges...
Article
Objectives: Evidence is accumulating that progestogens may play a crucial role in the development of breast cancer under contraception and hormone therapy in reproductive and menopausal women. Progesterone receptor membrane component 1 (PGRMC1) expressed in breast cancer may be important in tumorigenesis and thus may increase breast cancer risk. T...
Article
Fragestellung: Gestagene scheinen eine entscheidende Rolle bei der Entstehung eines Mammakarzinoms in Bezug auf die Empfangnisverhutung und die Hormontherapie in der Postmenopause zu spielen. Die Progesteronrezeptor-Membrankomponente 1 (PGRMC1), die in Mammakarzinom-Zellen exprimiert ist, konnte fur die Tumorgenese wichtig sein und somit das Brustk...
Article
Breast cancer risk is still an important topic regarding hormone therapy as well as oral contraception. Evidence that progestogens may play a crucial role is accumulating. Progesterone receptor membrane component 1 (PGRMC1) expressed in breast cancer may be important in tumorigenesis and thus may increase breast cancer risk. The aim of this project...
Article
Progestogens influence mammary gland development and probably breast cancer tumorigenesis by regulating a broad spectrum of physiological processes. We investigated receptor membrane-initiated actions of progestogens in MCF-7 breast cancer cells overexpressing progesterone receptor membrane component 1 (PGRMC1). MCF-7 cells were stably transfected...
Article
Full-text available
Human group IIA-secreted phospholipase A2 (sPLA2-IIA) is an important regulator of cytokine-mediated inflammatory responses in both in vitro and in vivo models of rheumatoid arthritis (RA). However, treatment of RA patients with sPLA2-IIA inhibitors shows only transient benefit. Using an activity-impaired sPLA2-IIA mutant protein (H48Q), we show th...
Patent
The present invention relates to the use of an active ingredient and to a method for the prevention or treatment of tumors, the diagnostic detection of disorders associated with these tumors, and pharmaceutical compositions and kits related thereto.
Article
Progesterone influences mammary gland development and probably breast cancer tumorigenesis and functions by regulating a broad spectrum of physiological processes. We investigated receptor membrane-initiated actions of progesterone in MCF-7 breast cancer cells via progesterone receptor membrane component 1 (PGRMC1). The expression of PGRMC1 in brea...
Article
Full-text available
Following the publication of our article [1] we noticed an error in the abstract, within the paragraph headed 'Results'. The serine residue, serine-181, referred to in this paragraph should be serine-180. The paragraph should therefore read as follows: Proteins significantly differentially abundant between estro-gen receptor negative and estrogen r...
Chapter
2D-PAGE remains a widely employed proteomics method because it provides the highest separating resolution of intact polypeptide isoforms that are amenable to subsequent characterization (1, 2). ProteoTope is a differential radioactive detection method that we developed based upon temporally separated exposures of iodinated proteins on 2D-PAGE gels...
Chapter
It has long been apparent that the separation capacity of conventional 18 cm IPGs as the first separation step in two dimensional polyacrylamide gel electro-phoresis (2D-PAGE) was theoretically incapable of separating the complexity that is to be expected by the protein species of a mammalian cell line or tissue (1). We first attempted to improve t...
Article
Full-text available
To identify pretherapeutic predictive biomarkers in tumor biopsies of patients with locally advanced esophageal adenocarcinomas treated with neoadjuvant chemotherapy, we used an explorative proteomic approach to correlate pretherapeutic protein expression profiles with tumor response to neoadjuvant chemotherapy. Thirty-four patients with locally ad...
Article
Full-text available
Breast tumors lacking the estrogen receptor-alpha (ER-alpha) have increased incidence of resistance to therapy and poorer clinical prognosis. Whole tissue sections from 16 cryopreserved breast cancer tumors that were either positive or negative for the ER (eight ER positive and eight ER negative) were differentially analyzed by multiplex imaging of...
Data
Supplementary materials. Presented are Supplementary discussions entitled 'Validation of the differential abundance profile' and 'Candidate PGRMC1 interacting proteins'. It additionally contains two supplementary tables: Table S1 ('Protein spots that contained multiple identifications of individual proteins as gene products') and Table S2 ('Clinica...
Article
Die Progesteronrezeptor-Membrankomponente 1 (PGRMC1) ist ein 28kDa Protein, das zur „membrane-associated progesterone receptor“ (MAPR) Proteinfamilie gehort. Wir konnten zeigen, dass PGRMC1 im ER-negativen Mammakarzinom hochreguliert und phosphoryliert ist. Ziel dieser Studie war die weitergehende Charakterisierung des PGRMC1 beim Mammakarzinom. PG...
Article
Besides the mitogenic action of estrogens in breast cancer cells there is also evidence that estrogen receptors mediate protective, anti-invasive effects. The aim of this project was to identify downstream ER-dependent proteins differentially expressed in fresh-frozen ER-positive and –negative breast cancer. Tissue sections from eight ER-positive a...
Article
Living mice were subjected to whole body labeling by intravenous infusion of [(13)C]glucose as the sole carbon source. After 10 h infusion the mice were sacrificed, and liver proteins were separated by two-dimensional polyacrylamide gel electrophoresis. Five spots were found to contain mitochondrial aldehyde dehydrogenase (ALDH2) by matrix assisted...
Article
Progesterone receptor membrane component 1 (PGRMC1) contains a cytochrome b5 domain fold and belongs to the so-called membrane-associated progesterone receptor (MAPR) protein family that is widespread in eukaryotes. PGRMC1 and the related PGRMC2 mammalian family member diverged sometime after the evolution of segmented metazoan body plan and the ap...
Article
Breast cancer is one of the most common cancers observed in women in industrialized Western countries. The development of novel diagnostic methods and the application of modern systemic therapies have significantly optimized early detection and therapy of breast cancer. However, many patients are currently overtreated. Traditionally, tumours have b...